Dose Ranging and Dose Frequency of LIPO-102

Completed · Phase 2 · Has a placebo group

Conditions studied: Subcutaneous Adipose Tissue Reduction

In brief

Dose Ranging and Dose Frequency of LIPO-102

Key facts

Study ID

NCT00918814

Run by

Neothetics, Inc

People needed

54

Starts

2009-06-01

Expected to finish

2010-02-01

Last updated by the study team

2015-03-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or non pregnant female
• Good general health
• Sufficient abdominal fat for injections
• Signed informed consent

You may not qualify if…

• Known hypersensitivity to study drugs
• Treatment with an investigational agent within 30 days of first dose

Where it is running

• Study site — San Diego, California, United States
• Study site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.